JFS Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.76K | Sell |
26
-23
| -47% | -$2.44K | ﹤0.01% | 1297 |
|
2025
Q1 | $6.08K | Sell |
49
-6
| -11% | -$745 | ﹤0.01% | 1041 |
|
2024
Q4 | $6.77K | Buy |
55
+8
| +17% | +$985 | ﹤0.01% | 997 |
|
2024
Q3 | $5.24K | Buy |
47
+2
| +4% | +$223 | ﹤0.01% | 1104 |
|
2024
Q2 | $4.8K | Hold |
45
| – | – | ﹤0.01% | 1078 |
|
2024
Q1 | $5.42K | Buy |
45
+8
| +22% | +$963 | ﹤0.01% | 1067 |
|
2023
Q4 | $4.55K | Buy |
37
+8
| +28% | +$984 | ﹤0.01% | 1098 |
|
2023
Q3 | $3.75K | Sell |
29
-6
| -17% | -$777 | ﹤0.01% | 1115 |
|
2023
Q2 | $4.34K | Sell |
35
-6
| -15% | -$744 | ﹤0.01% | 1066 |
|
2023
Q1 | $6K | Buy |
41
+5
| +14% | +$732 | ﹤0.01% | 914 |
|
2022
Q4 | $5.74K | Sell |
36
-1
| -3% | -$159 | ﹤0.01% | 936 |
|
2022
Q3 | $5K | Sell |
37
-3
| -8% | -$405 | ﹤0.01% | 984 |
|
2022
Q2 | $6K | Buy |
40
+4
| +11% | +$600 | ﹤0.01% | 939 |
|
2022
Q1 | $6K | Buy |
36
+23
| +177% | +$3.83K | ﹤0.01% | 977 |
|
2021
Q4 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 1094 |
|